Long-term survival in patients with metastatic melanoma who received ipilimumab in four phase II trials

被引：0
|
作者：
Lebbe, Celeste
Weber, Jeffrey S.
Maio, Michele
Neyns, Bart
Harmankaya, Kaan
Hamid, Omid
O'Day, Steven
Chin, Kevin M.
McDowell, Diane Opatt
Cykowski, Lori
McHenry, Brent
Wolchok, Jedd D.
机构：
[1] Hop St Louis, Paris, France
[2] Comprehens Melanoma Res Ctr, Moffitt Canc Ctr, Tampa, FL USA
[3] Univ Hosp Siena, Ist Toscano Tumori, Siena, Italy
[4] UZ Brussel, Brussels, Belgium
[5] Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, Vienna, Austria
[6] Angeles Clin & Res Inst, Santa Monica, CA USA
[7] Beverly Hills Canc Ctr, Beverly Hills, CA USA
[8] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[9] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9053
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials
    Wolchok, J. D.
    Weber, J. S.
    Maio, M.
    Neyns, B.
    Harmankaya, K.
    Chin, K.
    Cykowski, L.
    de Pril, V.
    Humphrey, R.
    Lebbe, C.
    ANNALS OF ONCOLOGY, 2013, 24 (08) : 2174 - 2180
  • [2] Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
    Schadendorf, Dirk
    Hodi, F. Stephen
    Robert, Caroline
    Weber, Jeffrey S.
    Margolin, Kim
    Hamid, Omid
    Patt, Debra
    Chen, Tai-Tsang
    Berman, David M.
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1889 - U48
  • [3] Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in metastatic or locally advanced, unresectable melanoma
    Schadendorf, D.
    Hodi, F. S.
    Robert, C.
    Weber, J. S.
    Margolin, K.
    Hamid, O.
    Chen, T. T.
    Berman, D. M.
    Wolchok, J. D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S11 - S11
  • [4] Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma
    Gibney, Geoffrey T.
    Atkins, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1873 - U27
  • [5] Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies
    Lebbe, C.
    Weber, J. S.
    Maio, M.
    Neyns, B.
    Harmankaya, K.
    Hamid, O.
    O'Day, S. J.
    Konto, C.
    Cykowski, L.
    McHenry, M. B.
    Wolchok, J. D.
    ANNALS OF ONCOLOGY, 2014, 25 (11) : 2277 - 2284
  • [6] Evaluation of the Long-Term Survival after Treatment with Ipilimumab or Vemurafenib in Patients with Metastatic Malignant Melanoma
    Rudolph, B. M.
    Groffik, A.
    Faidt, D.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 2 - 3
  • [7] Long-term survival benefit from ipilimumab treatment in metastatic uveal melanoma patients.
    Deo, Mugdha Anand
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Long-term survival in advanced melanoma patients treated with ipilimumab at 10 mg/kg: ongoing analyses from completed Phase II trials
    Maio, M.
    Lebbe, C.
    Sileni, V. Chiarion
    Siegel, J.
    Hoos, A.
    Humphrey, R.
    O'Day, S.
    Wolchok, J.
    Weber, J.
    Harmankaya, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 578 - 578
  • [9] Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: Report of a phase II study
    Neri, B.
    Vannozzi, L.
    Fulignati, C.
    Pantaleo, P.
    Pantalone, D.
    Paoletti, C.
    Perfetto, F.
    Turrini, M.
    Mazzanti, R.
    CANCER INVESTIGATION, 2006, 24 (05) : 474 - 478
  • [10] The Ipilimumab Lesson in Melanoma: Achieving Long-Term Survival
    Delyon, Julie
    Maio, Michele
    Lebbe, Celeste
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 387 - 401
12345